Skip to content

Comparison of Dexmedetomidine Versus Ketamine-Propofol ?combination versus Propofol for Sedation in Cataract Surgery

Comparison of Dexmedetomidine Versus Ketamine-Propofol ?combination versus Propofol for Sedation in Cataract Surgery

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20141209020258N148
Enrollment
96
Registered
2020-09-21
Start date
2020-06-30
Completion date
Unknown
Last updated
2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract. Age-related cataract

Interventions

Intervention 1: Intervention group 1: Dexmedetomidine dose of 0.5 microgram in kilogram will injected intravenously to patients in 10 minutes. Intervention 2: Intervention group: 20 milliliter of prop

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Age 18 to 85 years Both sexes Candidate for cataract surgery Absence of mental disorders Lack of chronic history of sedatives No alcohol and drugs Lack of allergy to the drugs used Absence of severe obstructive pulmonary disease and name No history of heart disease, heart block and bradycardia Absence of systolic blood pressure less than 90 mm Hg Absence of severe liver failure Absence of uncontrolled diabetes Absence of cerebrovascular diseases

Exclusion criteria

Exclusion criteria: Patient dissatisfaction Existence of any complication during sedation that leads to change of anesthesia schedule or cancellation of surgery.

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: Every 5 minutes in surgery and recovery. Method of measurement: Visual analog scale pain.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Alireza Kamali

Arak University of Medical Sciences

alikamaliir@yahoo.com+98 68 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026